1-83906450-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_024686.6(TTLL7):c.2006G>A(p.Arg669Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000098 in 1,611,700 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R669W) has been classified as Uncertain significance.
Frequency
Consequence
NM_024686.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TTLL7 | NM_024686.6 | c.2006G>A | p.Arg669Gln | missense_variant | 17/21 | ENST00000260505.13 | NP_078962.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TTLL7 | ENST00000260505.13 | c.2006G>A | p.Arg669Gln | missense_variant | 17/21 | 2 | NM_024686.6 | ENSP00000260505.8 |
Frequencies
GnomAD3 genomes AF: 0.0000922 AC: 14AN: 151902Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000104 AC: 26AN: 250024Hom.: 0 AF XY: 0.000104 AC XY: 14AN XY: 135136
GnomAD4 exome AF: 0.0000987 AC: 144AN: 1459680Hom.: 0 Cov.: 31 AF XY: 0.000110 AC XY: 80AN XY: 726150
GnomAD4 genome AF: 0.0000921 AC: 14AN: 152020Hom.: 0 Cov.: 32 AF XY: 0.0000673 AC XY: 5AN XY: 74288
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 23, 2022 | The c.2006G>A (p.R669Q) alteration is located in exon 17 (coding exon 16) of the TTLL7 gene. This alteration results from a G to A substitution at nucleotide position 2006, causing the arginine (R) at amino acid position 669 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at